Viracta Therapeutics | 4:持股变动声明-董事 ROYSTON IVOR
Viracta Therapeutics | 4:持股变动声明-董事 Pomerantz Roger
Viracta Therapeutics | SC 13G/A:超过5%持股股东披露文件(修正)-Biotechnology Value Fund, L.P.(0%),BVF I GP LLC(0%)等
Viracta Therapeutics | 4:持股变动声明-董事 ROYSTON IVOR
Viracta Therapeutics | 4:持股变动声明-董事 Pomerantz Roger
Viracta Therapeutics | 4:持股变动声明-董事 ROYSTON IVOR
Viracta Therapeutics | 4:持股变动声明-董事 Borellini Flavia
Viracta Therapeutics | 4:持股变动声明-董事 Chung Jane
Viracta Therapeutics | 4:持股变动声明-董事 Murphy Samuel Lafayette
Viracta Therapeutics | 4:持股变动声明-董事 DARCY THOMAS E
Viracta Therapeutics | 4:持股变动声明-董事 Simon Barry J.
Viracta Therapeutics | 4:持股变动声明-董事 Barlow Jane F
Viracta Therapeutics | 4:持股变动声明-董事 Pomerantz Roger
Viracta Therapeutics | 4:持股变动声明-董事 Rubino Stephen
Viracta Therapeutics | 4:持股变动声明-董事 Pomerantz Roger
Viracta Therapeutics | 4:持股变动声明-董事 ROYSTON IVOR
Viracta Therapeutics | 4:持股变动声明-高管 Faerm Michael E.
Viracta Therapeutics | 3:首次持股声明-高管 Faerm Michael E.
Viracta Therapeutics | 3:首次持股声明-高管 Burcar Melody
Viracta Therapeutics | 4:持股变动声明-高管 Rothera Mark